News & Updates

Show Multimedia Only

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout

13 Nov 2024 by

Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout

13 Nov 2024

Obesity linked to heightened risk of sleep-related breathing disorders in kids

13 Nov 2024

Children with obesity face an increased risk of sleep-related breathing disorders, similar to those with Prader-Willi syndrome, as reported in a retrospective study.

Obesity linked to heightened risk of sleep-related breathing disorders in kids

13 Nov 2024

Evidence supports semaglutide for obesity-related HFpEF

13 Nov 2024 by

Semaglutide improves exercise function in patients with obesity-related heart failure with preserved ejection fraction (HFpEF) in a secondary analysis of the prespecified pooled STEP-HFpEF and STEP-HFpEF DM trials presented at HFSA 2024.

Evidence supports semaglutide for obesity-related HFpEF

13 Nov 2024

Patients with acute anterior uveitis prone to ipsilateral recurrence

12 Nov 2024

Recurrence in the ipsilateral eye is not uncommon in nearly half of patients with acute anterior uveitis (AAU), while one in four may experience recurrence in the contralateral eye, suggests a study.

Patients with acute anterior uveitis prone to ipsilateral recurrence

12 Nov 2024

Vasopressin injection reduces bleeding, surgery time in ovarian endometrioma cystectomy

12 Nov 2024 by

In women with ovarian endometrioma, those who receive vasopressin injection during laparoscopic cystectomy experience shorter operation time, have reduced blood loss, and fewer coagulation events, as shown in a study presented at RCOG 2024.

Vasopressin injection reduces bleeding, surgery time in ovarian endometrioma cystectomy

12 Nov 2024

Faricimab trumps aflibercept in diabetic macular edema

12 Nov 2024

Treatment with faricimab demonstrates similar visual acuity and greater retinal thickness reduction, with fewer injections, when compared with aflibercept therapy in patients with diabetic macular edema (DME), reports a recent study.

Faricimab trumps aflibercept in diabetic macular edema

12 Nov 2024

Early smoking cessation boosts cancer survival

12 Nov 2024

Quitting smoking within 6 months after receiving a cancer diagnosis appears to confer survival benefits, according to a study.

Early smoking cessation boosts cancer survival

12 Nov 2024

Over 39M people could die from superbugs by 2050

12 Nov 2024 by

More than 39 million people worldwide could die from antibiotic-resistant infections from 2025 to 2050 as the superbug crisis intensifies, according to a new global analysis of antimicrobial resistance.

Over 39M people could die from superbugs by 2050

12 Nov 2024

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

12 Nov 2024 by

Including adjuvant nivolumab as part of a perioperative regimen for resectable NSCLC further improves the EFS benefit vs including nivolumab in a neoadjuvant-only setting, as suggested by a patient-level data analysis of CheckMate 77T and CheckMate 816 investigating each modality separately

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

12 Nov 2024

Prompt DOAC therapy after stroke safe for AF patients

11 Nov 2024 by

Initiating direct oral anticoagulants (DOACs) within 4 days after an ischaemic stroke in patients with atrial fibrillation (AF) is safe and yields similar outcomes as delayed initiation, as shown in the phase 4 OPTIMAS trial.

Prompt DOAC therapy after stroke safe for AF patients

11 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout

Obesity linked to heightened risk of sleep-related breathing disorders in kids

Obesity linked to heightened risk of sleep-related breathing disorders in kids

Evidence supports semaglutide for obesity-related HFpEF

Evidence supports semaglutide for obesity-related HFpEF

Patients with acute anterior uveitis prone to ipsilateral recurrence

Patients with acute anterior uveitis prone to ipsilateral recurrence

Vasopressin injection reduces bleeding, surgery time in ovarian endometrioma cystectomy

Vasopressin injection reduces bleeding, surgery time in ovarian endometrioma cystectomy

Faricimab trumps aflibercept in diabetic macular edema

Faricimab trumps aflibercept in diabetic macular edema

Early smoking cessation boosts cancer survival

Early smoking cessation boosts cancer survival

Over 39M people could die from superbugs by 2050

Over 39M people could die from superbugs by 2050

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

EFS benefit greater with perioperative vs neoadjuvant-only nivolumab in resectable NSCLC

Prompt DOAC therapy after stroke safe for AF patients

Prompt DOAC therapy after stroke safe for AF patients